JP2006036795A5 - - Google Patents

Download PDF

Info

Publication number
JP2006036795A5
JP2006036795A5 JP2005305068A JP2005305068A JP2006036795A5 JP 2006036795 A5 JP2006036795 A5 JP 2006036795A5 JP 2005305068 A JP2005305068 A JP 2005305068A JP 2005305068 A JP2005305068 A JP 2005305068A JP 2006036795 A5 JP2006036795 A5 JP 2006036795A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2005305068A
Other languages
Japanese (ja)
Other versions
JP2006036795A (ja
Filing date
Publication date
Priority claimed from US07/870,985 external-priority patent/US6455492B1/en
Application filed filed Critical
Publication of JP2006036795A publication Critical patent/JP2006036795A/ja
Publication of JP2006036795A5 publication Critical patent/JP2006036795A5/ja
Withdrawn legal-status Critical Current

Links

JP2005305068A 1992-01-17 2005-10-19 Ｅ型肝炎ウィルスワクチン及びその接種方法 Withdrawn JP2006036795A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82233592A 1992-01-17 1992-01-17
US07/870,985 US6455492B1 (en) 1988-06-17 1992-04-20 Hepatitis E virus vaccine and method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP51271493A Division JP3746291B2 (ja) 1992-01-17 1993-01-19 Ｅ型肝炎ウィルスワクチン及びその接種方法

Publications (2)

Publication Number Publication Date
JP2006036795A JP2006036795A (ja) 2006-02-09
JP2006036795A5 true JP2006036795A5 (enExample) 2007-06-14

Family

ID=27124631

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51271493A Expired - Fee Related JP3746291B2 (ja) 1992-01-17 1993-01-19 Ｅ型肝炎ウィルスワクチン及びその接種方法
JP2005305068A Withdrawn JP2006036795A (ja) 1992-01-17 2005-10-19 Ｅ型肝炎ウィルスワクチン及びその接種方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51271493A Expired - Fee Related JP3746291B2 (ja) 1992-01-17 1993-01-19 Ｅ型肝炎ウィルスワクチン及びその接種方法

Country Status (9)

Country Link
US (3) US6455492B1 (enExample)
EP (1) EP0623169B1 (enExample)
JP (2) JP3746291B2 (enExample)
AT (1) ATE236255T1 (enExample)
CA (1) CA2125701A1 (enExample)
DE (1) DE69332820T2 (enExample)
DK (1) DK0623169T3 (enExample)
ES (1) ES2196008T3 (enExample)
WO (1) WO1993014208A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789559A (en) * 1988-06-17 1998-08-04 Genelabs Technologies, Inc. DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent
US6214970B1 (en) 1988-06-17 2001-04-10 Genelabs Technologies, Inc. Hepatitis E virus antigens and uses therefor
US5686239A (en) * 1988-06-17 1997-11-11 Genelabs Technologies, Inc. Hepatitis E virus peptides and methods
US6455492B1 (en) * 1988-06-17 2002-09-24 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
US6291641B1 (en) 1988-06-17 2001-09-18 Genelabs Technologies, Inc. Hepatitis E virus antigens and uses therefor
US6207416B1 (en) 1992-09-18 2001-03-27 The United States Of America As Represented By The Department Of Health And Human Services Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
EP0662133B1 (en) 1992-09-18 2009-11-18 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
US6787145B1 (en) 1992-09-18 2004-09-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
US5736315A (en) * 1992-10-21 1998-04-07 National Institute Of Health Methods and compositions for detecting anti-hepatitis E virus activity
US5563032A (en) * 1992-10-21 1996-10-08 The United States Of America As Represented By The Department Of Health And Human Services Mosaic polypeptide and methods for detecting the hepatitis E virus
AU694139B2 (en) * 1993-09-24 1998-07-16 Macfarlane Burnet Centre For Medical Research Limited, The Immunoreactive antigens of hepatitis E virus
WO1995017501A1 (en) * 1993-12-22 1995-06-29 Abbott Laboratories Monoclonal antibodies against hev orf-2 and methods for using same
JPH09507749A (ja) * 1993-12-22 1997-08-12 アボツト・ラボラトリーズ Ｅ型肝炎ウイルスに対するモノクローナル抗体及びそれらを使用する方法
US5830636A (en) * 1993-12-22 1998-11-03 Abbott Laboratories HEV orf-2 monoclonal antibodies and methods for using same
US6054567A (en) * 1997-04-11 2000-04-25 The United States Of America As Represented By The Department Of Health And Human Services Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
US6458562B1 (en) 1998-04-09 2002-10-01 The United States Of America As Represented By The Secretary Of Health And Human Services Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines
CA2283538A1 (en) * 1999-09-30 2001-03-30 Mun Hon Ng New hev antigenic peptide and methods
US7005130B2 (en) * 2001-01-05 2006-02-28 Virginia Tech Intellectual Properties, Inc. Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
US20030220475A1 (en) * 2001-04-03 2003-11-27 Fields Howard A. Neutralizing immunogenic hev polypepetides
US6614586B2 (en) * 2001-07-30 2003-09-02 Dorsal Networks, Inc. Methods and systems for high performance, wide bandwidth optical communication systems using Raman amplification
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
RU2501568C1 (ru) * 2012-04-27 2013-12-20 Закрытое акционерное общество научно-производственная компания "Комбиотех" Рекомбинантная вакцина для профилактики вирусного гепатита е у животных
RU2501809C1 (ru) * 2012-04-27 2013-12-20 Закрытое акционерное общество научно-производственная компания "Комбиотех" Способ получения рекомбинантного капсидного белка вируса гепатита е и рекомбинантная вакцина для профилактики вирусного гепатита е
RU2493249C1 (ru) * 2012-04-27 2013-09-20 Закрытое акционерное общество научно-производственная компания "Комбиотех" Рекомбинантный штамм дрожжей hansenula polymorpha - продуцент капсидного белка вируса гепатита е
EP3820892B1 (en) * 2018-07-10 2024-01-03 Institut National de la Santé et de la Recherche Médicale (INSERM) Antibodies having specificity for the orf2i protein of hepatitis e virus and uses thereof for diagnostic purposes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5218099A (en) * 1986-04-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Post-transfusion, non-A, non-B hepatitis virus polynucleotides
FR2597606B1 (fr) * 1986-04-16 1989-10-06 Pasteur Institut Nouveau reactif pour la detection d'hepatites virales non a non b et procede de diagnostic de telles hepatites par voie immunoenzymatique
US5686239A (en) * 1988-06-17 1997-11-11 Genelabs Technologies, Inc. Hepatitis E virus peptides and methods
AU644878B2 (en) * 1988-06-17 1993-12-23 Genelabs Technologies, Inc. Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof
US6455492B1 (en) * 1988-06-17 2002-09-24 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
AU3748489A (en) * 1988-06-17 1990-01-12 Genelabs Incorporated Enterically transmitted non-a/non-b hepatitis viral agent
US5741490A (en) * 1988-06-17 1998-04-21 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
US5885768A (en) * 1988-06-17 1999-03-23 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis E virus peptide antigen and antibodies
US5202430A (en) * 1990-01-16 1993-04-13 University Of Tennessee Transmissible gastroenteritis virus genes
JPH04200388A (ja) * 1990-11-29 1992-07-21 Chemo Sero Therapeut Res Inst 流行性非ａ非ｂ型肝炎ウイルス抗原ペプチドおよびこれをコードする核酸断片
EP0662133B1 (en) * 1992-09-18 2009-11-18 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines

Similar Documents

Publication Publication Date Title
BE2021C519I2 (enExample)
BE2021C524I2 (enExample)
BE2013C074I2 (enExample)
BE2013C014I2 (enExample)
BE2012C042I2 (enExample)
BRPI0601358B8 (pt) Aplicador de clipe cirúrgico
BRPI0601402B8 (pt) Aplicador de grampos cirúrgicos
BR122017004709A2 (enExample)
BRPI0609157A8 (enExample)
BE2019C013I2 (enExample)
BRPI0608519A2 (enExample)
BR122020005056A2 (enExample)
JP2006036795A5 (enExample)
AP2140A (enExample)
BR122016029989A2 (enExample)
BRPI0604219A (enExample)
BRPI0618215B8 (enExample)
BY2237U (enExample)
BE2017C062I2 (enExample)
CN105122969C (enExample)
CN300725999S (zh) 鞋底
CN300726004S (zh) 鞋帮
CN300726591S (zh) 冷冰食品制作器
CN300726508S (zh) 头部遮挡板
CN300726222S (zh) 包装纸(金色高金火腿肠)